People: Nektar Therapeutics (NKTR.OQ)
Mr. John L Nicholson is Chief Operating Officer, Senior Vice President of the Company. Mr. Nicholson joined the Company as Senior Vice President of Corporate Development and Business Operations in October 2007 and was appointed Senior Vice President and Chief Financial Officer in December 2007 and served as our Chief Financial Officer until June 2016 when he was promoted to Senior Vice President and Chief Operating Officer. Before joining Nektar, Mr. Nicholson spent 18 years in various executive roles at Schering Berlin, Inc., the U.S. management holding company of Bayer Schering Pharma AG, a pharmaceutical company. From 1997 to September 2007, Mr. Nicholson served as Schering Berlin Inc.’s Vice President of Corporate Development and Treasurer. From 2001 to September 2007, he concurrently served as President of Schering Berlin Insurance Co., and from February 2007 through September 2007, he also concurrently served as President of Bayer Pharma Chemicals and Schering Berlin Capital Corp. Mr. Nicholson holds a B.B.A. from the University of Toledo.
|Total Annual Compensation, USD||1,173,380|
|Restricted Stock Award, USD||2,958,790|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||3,698,990|
|Fiscal Year Total, USD||7,831,160|